Lincluden Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.27M | Sell |
302,092
-99,218
| -25% | -$2.6M | 0.71% | 32 |
|
|
2026
Q1 | $11.3M | Buy |
401,310
+12,107
| +3% | +$322K | 1.2% | 20 |
|
|
2025
Q4 | $9.69M | Sell |
389,203
-22,825
| -6% | -$576K | 0.82% | 23 |
|
|
2025
Q3 | $10.5M | Sell |
412,028
-1,530
| -0.4% | -$37.8K | 1.17% | 20 |
|
|
2025
Q2 | $10M | Sell |
413,558
-1,896
| -0.5% | -$44.2K | 1.11% | 22 |
|
|
2025
Q1 | $10.5M | Buy |
415,454
+29,617
| +8% | +$775K | 1.34% | 19 |
|
|
2024
Q4 | $10.2M | Sell |
385,837
-1,271
| -0.3% | -$34.5K | 1.24% | 20 |
|
|
2024
Q3 | $11.2M | Buy |
387,108
+35,254
| +10% | +$1.03M | 1.22% | 20 |
|
|
2024
Q2 | $9.85M | Sell |
351,854
-3,376
| -1% | -$92.9K | 1.2% | 20 |
|
|
2024
Q1 | $9.86M | Sell |
355,230
-2,313
| -0.6% | -$64.2K | 1.17% | 19 |
|
|
2023
Q4 | $10.3M | Buy |
357,543
+48,517
| +16% | +$1.47M | 1.25% | 16 |
|
|
2023
Q3 | $10.3M | Buy |
309,026
+32,684
| +12% | +$1.16M | 1.24% | 16 |
|
|
2023
Q2 | $10.1M | Sell |
276,342
-990
| -0.4% | -$38.5K | 1.17% | 19 |
|
|
2023
Q1 | $11.3M | Sell |
277,332
-1,200
| -0.4% | -$51.8K | 1.29% | 18 |
|
|
2022
Q4 | $14.3M | Sell |
278,532
-2,389
| -0.9% | -$115K | 1.66% | 17 |
|
|
2022
Q3 | $12.3M | Sell |
280,921
-18,014
| -6% | -$875K | 1.57% | 16 |
|
|
2022
Q2 | $15.7M | Sell |
298,935
-4,418
| -1% | -$225K | 1.72% | 15 |
|
|
2022
Q1 | $15.7M | Sell |
303,353
-3,050
| -1% | -$158K | 1.39% | 16 |
|
|
2021
Q4 | $18.1M | Sell |
306,403
-5,450
| -2% | -$270K | 1.65% | 16 |
|
|
2021
Q3 | $13.4M | Sell |
311,853
-46,714
| -13% | -$2.07M | 1.35% | 18 |
|
|
2021
Q2 | $14M | Sell |
358,567
-20,910
| -6% | -$813K | 1.35% | 17 |
|
|
2021
Q1 | $13.7M | Buy |
379,477
+200,029
| +111% | +$7.1M | 1.33% | 16 |
|
|
2020
Q4 | $6.61M | Sell |
179,448
-17,669
| -9% | -$648K | 0.69% | 29 |
|
|
2020
Q3 | $6.86M | Sell |
197,117
-6,324
| -3% | -$222K | 0.68% | 25 |
|
|
2020
Q2 | $6.31M | Sell |
203,441
-12,142
| -6% | -$413K | 0.66% | 28 |
|
|
2020
Q1 | $6.68M | Buy |
215,583
+27,609
| +15% | +$941K | 0.8% | 25 |
|
|
2019
Q4 | $6.99M | Buy |
187,974
+16,944
| +10% | +$604K | 0.63% | 27 |
|
|
2019
Q3 | $5.83M | Sell |
171,030
-364
| -0.2% | -$13.2K | 0.54% | 26 |
|
|
2019
Q2 | $7.04K | Sell |
171,394
-416
| -0.2% | -$16.5K | 0.45% | 21 |
|
|
2019
Q1 | $6.92M | Sell |
171,810
-9,360
| -5% | -$375K | 0.66% | 23 |
|
|
2018
Q4 | $7.5M | Sell |
181,170
-12,991
| -7% | -$539K | 0.58% | 22 |
|
|
2018
Q3 | $8.12M | Sell |
194,161
-24,837
| -11% | -$956K | 0.68% | 35 |
|
|
2018
Q2 | $7.54M | Sell |
218,998
-1,997
| -0.9% | -$68.2K | 0.55% | 37 |
|
|
2018
Q1 | $7.44M | Buy |
220,995
+2,698
| +1% | +$92.8K | 0.6% | 36 |
|
|
2017
Q4 | $7.5M | Sell |
218,297
-14,840
| -6% | -$506K | 0.52% | 38 |
|
|
2017
Q3 | $7.9M | Buy |
233,137
+84,119
| +56% | +$2.7M | 0.61% | 36 |
|
|
2017
Q2 | $4.75M | Sell |
149,018
-1,129
| -0.8% | -$35.6K | 0.41% | 42 |
|
|
2017
Q1 | $4.87M | Sell |
150,147
-9,179
| -6% | -$289K | 0.44% | 43 |
|
|
2016
Q4 | $4.91M | Sell |
159,326
-21,030
| -12% | -$642K | 0.54% | 41 |
|
|
2016
Q3 | $5.8M | Buy |
180,356
+8,184
| +5% | +$274K | 0.85% | 38 |
|
|
2016
Q2 | $5.75M | Buy |
172,172
+2,508
| +1% | +$80K | 0.95% | 36 |
|
|
2016
Q1 | $4.77M | Buy |
169,664
+10,460
| +7% | +$299K | 0.81% | 40 |
|
|
2015
Q4 | $4.88M | Sell |
159,204
-16,126
| -9% | -$507K | 0.99% | 35 |
|
|
2015
Q3 | $5.22M | Sell |
175,330
-28,890
| -14% | -$926K | 1.01% | 33 |
|
|
2015
Q2 | $6.5K | Sell |
204,220
-41,522
| -17% | -$1.35M | 0.8% | 33 |
|
|
2015
Q1 | $8.11M | Sell |
245,742
-2,506
| -1% | -$79.7K | 1.16% | 30 |
|
|
2014
Q4 | $7.34M | Sell |
248,248
-1,844
| -0.7% | -$52.9K | 0.72% | 37 |
|
|
2014
Q3 | $7.02M | Buy |
250,092
+17,159
| +7% | +$482K | 0.68% | 41 |
|
|
2014
Q2 | $6.56M | Buy |
232,933
+25,217
| +12% | +$719K | 0.6% | 48 |
|
|
2014
Q1 | $6.33M | Sell |
207,716
-71,871
| -26% | -$2.14M | 0.59% | 46 |
|
|
2013
Q4 | $8.13M | Buy |
279,587
+14,424
| +5% | +$420K | 0.74% | 38 |
|
|
2013
Q3 | $7.23M | Sell |
265,163
-30,967
| -10% | -$843K | 0.9% | 36 |
|
|
2013
Q2 | $7.87K | Buy |
+296,130
| New | +$8.18M | 0.02% | 38 |
|
Other funds holding PFE
Lincluden Management's PFE Position: Q2 2026 in Review
Lincluden Management reduced its Pfizer (PFE) stake by 25% in Q2 2026, selling an estimated $2.6M and leaving 302,092 shares worth $7.27M. The position accounts for 0.71% of the portfolio, ranked #32.
Lincluden Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $18.1M in Q4 2021. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Lincluden Management held 302,092 shares of Pfizer worth $7.27M as of Q2 2026.
- Lincluden Management sold 99,218 Pfizer shares in Q2 2026, an estimated $2.6M.
- Pfizer made up 0.71% of Lincluden Management's portfolio in Q2 2026, its #32 holding.
- Lincluden Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Lincluden Management's Pfizer position peaked at $18.1M in Q4 2021.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Lincluden Management's 13F filing for Q2 2026, filed 24 Jul 2026.